This interview reviews the current challenges to patients and their care teams and highlights how advancing technologies can facilitate the delivery of care.
One such technology is Aptar Pharma’s HeroTracker® Sense. This innovation has the potential to reduce the burden of chronic respiratory diseases on HCPs, nurse practitioners and patients. This novel connected healthcare device transforms a standard metered dose inhaler into a connected healthcare device. It provides valuable feedback to patients to help them use their pMDI as intended and supports their inhalation technique. It also provides valuable analytics to the HCP and insights into patient training and onboarding, thereby helping care teams to better understand real-life situations and use of pMDIs, and adapt treatment plans accordingly.
Learn more about Aptar Pharma’s expertise in Digital Health
This Might Also Be of Interest

Digital Health and Oncology Innovations in Subcutaneous Administration
Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Elevating Medication Adherence and Clinical Outcomes with Connected Drug Delivery
Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation

Patient-Focused Cancer Care: Harnessing Immunotherapy
Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations

The Potential of Digital Health in Empowering Patients with Cancer
Webinars, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions